Developmental effects of sesamolin on zebrafish (Danio rerio) embryos

Sesamolin is one of the major active compounds found in sesame seeds ( Sesamum indicum L.) that are commonly and increasingly used as an ingredient in cuisines and various food products. The compound has been reported to have several pharmaceutical activities such as antioxidant, antimicrobial, neuroprotective, and anticancer. However, the toxicological profile of sesamolin does not currently include developmental toxicity. In this study, we assessed sesamolin toxicity to embryonic development of zebrafish by exposure for 72 h at concentrations ranging from 10 to 50 μM. The evaluation revealed that sesamolin did not affect survival and hatching rates. However, it did induce embryo malformations and reduced embryonic heart rates in a dose-dependent manner. By qRT-PCR analysis, it downregulated the expression of oxidative stress-related genes, including superoxide dismutase 1 ( sod1 ), catalase ( cat ), and glutathione S-transferase pi 2 ( gstp2 ). Alkaline phosphatase staining of embryos revealed that sesamolin inhibited the development of subintestinal vessels, and hemoglobin staining revealed a negative impact on embryonic erythropoiesis. These findings showed that sesamolin affected genes related to angiogenesis and erythropoiesis. The risks of sesamolin to embryonic development found in this study may imply similar effects in humans and other mammals. • Sesamolin induces malformations in zebrafish embryos. • Sesamolin decreases heart rate of zebrafish embryos. • Sesamolin disrupts hematopoiesis and angiogenesis in zebrafish embryos.